CompaniesKyorin Pharmaceutical

Kyorin Pharmaceutical

active
Tokyo, Japan
Founded 1923
Website
About

Small Molecules

Areas of Focus

Categories

Small Molecule PharmaceuticalJapan
Clinical Trials (11)
View all

Total Trials

11

As Lead Sponsor

4

As Collaborator

7

Total Enrollment

9,827

By Phase

NA: 2PHASE3: 2PHASE1: 1PHASE4: 1PHASE2: 2

By Status

COMPLETED: 10ACTIVE_NOT_RECRUITING: 1
Clinical Trials Pipeline11 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2004
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Today
NCT00512785
Hover over trial bars to see details

Recent Trials

NCT05685342Collaborator
Preemptive and Preventive Acetaminophen/Ibuprofen Fixed-dose Combination After Robot-assisted Radical Prostatectomy
NACompleted
154 participants
Started: Feb 10, 2023 · Completed: Jul 30, 2025
NCT05366777Collaborator
Intravenous Acetaminophen/Ibuprofen Fixed-dose Combination on Postoperative Opioid Consumption
NACompleted
96 participants
Started: Oct 3, 2022 · Completed: Oct 15, 2023
NCT05415137Collaborator
Efficacy and Safety of Intravenous Efzofitimod in Patients With Pulmonary Sarcoidosis
PHASE3Active, not recruiting
268 participants
Started: Sep 15, 2022 · Completed: Aug 31, 2025
NCT04908800Lead Sponsor
A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of KRP-A218 in Healthy Subjects
PHASE1Completed
99 participants
Started: May 27, 2021 · Completed: Apr 21, 2022
NCT01654783Lead Sponsor
Observational Study in the Management of Ulcerative Colitis With Oral 5-ASA
N/ACompleted
5,704 participants
Started: Sep 30, 2012 · Completed: Jun 30, 2014
View all 11 trials →
Locations (1)
Headquarters
Tokyo, Japan
Map

Loading map...